» Articles » PMID: 9005853

Identification of a Gene That Causes Primary Open Angle Glaucoma

Overview
Journal Science
Specialty Science
Date 1997 Jan 31
PMID 9005853
Citations 507
Authors
Affiliations
Soon will be listed here.
Abstract

Glaucoma is a major cause of blindness and is characterized by progressive degeneration of the optic nerve and is usually associated with elevated intraocular pressure. Analyses of sequence tagged site (STS) content and haplotype sharing between families affected with chromosome 1q-linked open angle glaucoma (GLC1A) were used to prioritize candidate genes for mutation screening. A gene encoding a trabecular meshwork protein (TIGR) mapped to the narrowest disease interval by STS content and radiation hybrid mapping. Thirteen glaucoma patients were found to have one of three mutations in this gene (3.9 percent of the population studied). One of these mutations was also found in a control individual (0.2 percent). Identification of these mutations will aid in early diagnosis, which is essential for optimal application of existing therapies.

Citing Articles

Structural basis for anomalous cellular trafficking behavior of glaucoma-associated A427T mutant myocilin.

Hill K, Scelsi H, Youngblood H, Faralli J, Itakura T, Fini M bioRxiv. 2025; .

PMID: 40060664 PMC: 11888440. DOI: 10.1101/2025.02.26.640437.


Corneal Stromal Stem Cell-Derived Extracellular Vesicles Attenuate ANGPTL7 Expression in the Human Trabecular Meshwork.

Moujane F, Zhang C, Knight R, Lee J, Deng S, Zheng J Transl Vis Sci Technol. 2025; 14(1):21.

PMID: 39847376 PMC: 11759583. DOI: 10.1167/tvst.14.1.21.


Identification of mutation of MYOC (c.1099G>A), a pedigree pathogenic gene of juvenile open angle glaucoma (JOAG): A case report.

Zheng J, Zhao D, Li Z, Feng C, Song Z, Li R Medicine (Baltimore). 2025; 103(47):e40555.

PMID: 39809167 PMC: 11596615. DOI: 10.1097/MD.0000000000040555.


Genetic engineering and the eye.

Murphy R, Martin K Eye (Lond). 2024; 39(1):57-68.

PMID: 39516652 PMC: 11733221. DOI: 10.1038/s41433-024-03441-2.


Gene therapy for glaucoma: Targeting key mechanisms.

Henderson J, OCallaghan J, Campbell M Vision Res. 2024; 225:108502.

PMID: 39423611 PMC: 11579448. DOI: 10.1016/j.visres.2024.108502.